+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: microbiological and clinical features



Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain: microbiological and clinical features



Journal of Clinical Microbiology 49(3): 1134-1136



Extended-spectrum β-lactamases (ESBL) of the CTX-M, SHV, and TEM families were recognized in 76 (67%), 31 (27%), and 6 (5%) isolates, respectively, among 162 ESBL-producing Klebsiella pneumoniae (ESBL-Kp) strains obtained in a multicenter study in Spain. Predisposing factors for ESBL-Kp acquisition included invasive procedures, mechanical ventilation, and previous antimicrobial use.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 054047572

Download citation: RISBibTeXText

PMID: 21191059

DOI: 10.1128/jcm.02514-10


Related references

Isolation of Escherichia coli and Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases in Spain A nationwide Study. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 115, 2002

Characterization of Klebsiella pneumoniae strains producing extended spectrum beta-lactamases and AMPC type beta-lactamases isolated from hospitalized patients in Kerman, Iran. Roumanian Archives of Microbiology and Immunology 71(2): 81-86, 2012

Detection of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Abstracts of the General Meeting of the American Society for Microbiology 98: 134, 1998

Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrobial Agents and ChemoTherapy 49(5): 2122-2125, 2005

Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. Journal of Clinical Microbiology 32(3): 691-696, 1994

Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Antimicrobial Agents and ChemoTherapy 48(9): 3477-3482, 2004

Effectiveness of cefpirome on Klebsiella pneumoniae strains producing extended spectrum beta-lactamases (ESBL). Epidemiologie Mikrobiologie Imunologie 47(1): 12-14, 1998

Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea. Journal of Clinical Microbiology 36(5): 1446-1449, 1998

Strains of Klebsiella pneumoniae producing extended spectrum beta-lactamases, isolated from organ recipients. Transplantation Proceedings 43(8): 3128-3129, 2011

Biofilm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum beta-lactamases. Journal of Hospital Infection 68(4): 369-371, 2008

Evaluation of six beta-lactam substrates for the detection of extended spectrum beta-lactamases producing Klebsiella pneumoniae strains from Brazil. Abstracts of the General Meeting of the American Society for Microbiology 97: 207, 1997

Transfer of resistance to 3rd generation cephalosporins and aztreonam in strains of Klebsiella pneumoniae producing extended spectrum beta-lactamases. Epidemiologie Mikrobiologie Imunologie 48(1): 21-27, 1999

Cefotetan -cloxacillin synergy test for differentiation of Klebsiella pneumoniae producing plasmid-mediated AmpC-type beta-lactamase from strains producing extended-spectrum beta-lactamases and deficient in porins. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 168, 2003

Transferable resistance to 3rd generation cephalosporins and aztreonam in strains of Klebsiella pneumoniae producing beta-lactamases with an extended spectrum (ESBL). Epidemiologie Mikrobiologie Imunologie 48(1): 21-27, 1999

First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum beta-lactamases in Korea. Antimicrobial Agents and ChemoTherapy 49(11): 4809-4810, 2005